Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy

[1] Glass JO(2006)Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate Magn Reson Imaging 24 785-791

[2] Reddick WE(2005)Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate AJNR Am J Neuroradiol 26 1263-1269

[3] Li CS(2008)Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment Developmental Disabilities Research Reviews 14 185-195

[4] Laningham FH(2003)White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy Radiology 229 659-669

[5] Helton KJ(2009)Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only Acta Paediatr 98 180-186

[6] Pui CH(2006)Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate J Clin Oncol 24 3858-3864

[7] Reddick WE(2004)Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity J Clin Oncol 22 2701-2707

[8] Glass JO(2002)CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory Med Pediatr Oncol 38 320-328

[9] Helton KJ(2007)A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia Pediatr Blood Cancer 49 65-73

[10] Langston JW(2000)Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia Arch Clin Neuropsychol 15 603-630

[1] Glass JO(2006)Computer-aided detection of therapy-induced leukoencephalopathy in pediatric acute lymphoblastic leukemia patients treated with intravenous high-dose methotrexate Magn Reson Imaging 24 785-791

[2] Reddick WE(2005)Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate AJNR Am J Neuroradiol 26 1263-1269

[3] Li CS(2008)Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment Developmental Disabilities Research Reviews 14 185-195

[4] Laningham FH(2003)White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy Radiology 229 659-669

[5] Helton KJ(2009)Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only Acta Paediatr 98 180-186

[6] Pui CH(2006)Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate J Clin Oncol 24 3858-3864

[7] Reddick WE(2004)Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity J Clin Oncol 22 2701-2707

[8] Glass JO(2002)CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory Med Pediatr Oncol 38 320-328

[9] Helton KJ(2007)A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia Pediatr Blood Cancer 49 65-73

[10] Langston JW(2000)Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia Arch Clin Neuropsychol 15 603-630